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Abstract
Synaptic long-term potentiation (LTP) at spinal neurons directly communicating pain-specific inputs from the periphery to
the brain has been proposed to serve as a trigger for pain hypersensitivity in pathological states. Previous studies have
functionally implicated the NMDA receptor-NO pathway and the downstream second messenger, cGMP, in these processes.
Because cGMP can broadly influence diverse ion-channels, kinases, and phosphodiesterases, pre- as well as post-
synaptically, the precise identity of cGMP targets mediating spinal LTP, their mechanisms of action, and their locus in the
spinal circuitry are still unclear. Here, we found that Protein Kinase G1 (PKG-I) localized presynaptically in nociceptor
terminals plays an essential role in the expression of spinal LTP. Using the Cre-lox P system, we generated nociceptor-
specific knockout mice lacking PKG-I specifically in presynaptic terminals of nociceptors in the spinal cord, but not in post-
synaptic neurons or elsewhere (SNS-PKG-I
2/2 mice). Patch clamp recordings showed that activity-induced LTP at identified
synapses between nociceptors and spinal neurons projecting to the periaqueductal grey (PAG) was completely abolished in
SNS-PKG-I
2/2 mice, although basal synaptic transmission was not affected. Analyses of synaptic failure rates and paired-
pulse ratios indicated a role for presynaptic PKG-I in regulating the probability of neurotransmitter release. Inositol 1,4,5-
triphosphate receptor 1 and myosin light chain kinase were recruited as key phosphorylation targets of presynaptic PKG-I in
nociceptive neurons. Finally, behavioural analyses in vivo showed marked defects in SNS-PKG-I
2/2 mice in several models of
activity-induced nociceptive hypersensitivity, and pharmacological studies identified a clear contribution of PKG-I expressed
in spinal terminals of nociceptors. Our results thus indicate that presynaptic mechanisms involving an increase in release
probability from nociceptors are operational in the expression of synaptic LTP on spinal-PAG projection neurons and that
PKG-I localized in presynaptic nociceptor terminals plays an essential role in this process to regulate pain sensitivity.
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Introduction
Plasticity in peripheral nociceptors and their synapses with
spinal neurons has been proposed as a cellular basis for the
development and maintenance of pain hypersensitivity following
peripheral inflammation or nerve injury [1–3]. Activation of
nociceptive nerve afferents at frequencies relevant to pathological
pain states can trigger long-term potentiation (LTP) at spinal
synapses between nociceptor terminals and spinal neurons
projecting nociceptive information to the brain [4,5]. Importantly,
PLoS Biology | www.plosbiology.org 1 March 2012 | Volume 10 | Issue 3 | e1001283this form of synaptic plasticity can be evoked by asynchronous
activation of nociceptors in vivo [5], occurs in humans [6], and is
functionally associated with a sensation of exaggerated pain [5,6].
Although there is evidence for a requirement of post-synaptic
calcium-dependent mechanisms in the induction of LTP at this
synapse [5], the precise mechanisms underlying the expression of
spinal LTP are not entirely clear [7].
Synaptic LTP evoked by natural, asynchronous low-rate
discharges in C-nociceptors on spino-PAG neurons was recently
shown to constitute a very fitting correlate of spinal amplification
phenomena underlying inflammatory pain [5,7]. This form of
synaptic change has been reported to involve activation of NMDA
receptors, NO release, and synthesis of cGMP [5,7]. However,
which of the diverse targets of cGMP come into play at this
synapse and how they mechanistically bring about long-lasting
changes in the transfer of nociceptive information between the
nociceptors and spinal neurons projecting to the brain is not
understood so far. Furthermore, very little is known about exactly
how neural circuits involved in pain processing are modulated by
cGMP and which cellular and molecular processes underlie these
changes.
Studies on several different biological systems have shown that
cGMP regulates multiple cellular targets, including diverse
cGMP-gated ion channels, such as cyclic nucleotide-gated
(CNG) and hyperpolarization-activated cyclic nucleotide-gated
(HCN) channels, the cGMP-dependent protein kinases, PKG-I/
cGK-I and PKG-II/cGK-II, as well as diverse phosphodiester-
ases (PDEs) [8,9]. Nearly all of these molecular targets of cGMP
are expressed in nociceptive pathways and may potentially
contribute to the key role of cGMP in synaptic potentiation in the
spinal cord. Amongst these targets, PKG-I has emerged as a key
mediator of cGMP functions in smooth muscle and platelet
function [8]. The a-isoform of PKG-I has been reported to be
expressed very highly in the primary sensory neurons in the
dorsal root ganglia (DRG) over developmental [10] and adult
stages [11], and several regions in the brain and the spinal cord
also express PKG-I [12,13]. Pharmacological and genetic studies
in global, constitutive mutant mice have linked PKG-I to the
development of the nociceptive circuitry as well as to spinal
mechanisms of hyperalgesia [14].
Based upon this background, this study was designed with two
goals in mind. First, it addressed the potential involvement of
presynaptic mechanisms in the expression of synaptic potentiation
on spinal projection neurons, which has not been explored or
described previously. Second, it aimed to explore a potential role
for PKG-I localized presynaptically in the spinal terminals of
nociceptors in spinal potentiation and to clarify cellular and
molecular mechanisms underlying these processes. We reasoned
that the use of a conditional, region-specific gene deletion strategy
to specifically manipulate presynaptic mechanisms might consti-
tute an unambiguous approach towards addressing the above
questions. Our results show that spinal synaptic potentiation
triggered by nociceptor activation is associated with a long-lasting
change in the probability of neurotransmitter release from spinal
terminals of nociceptors. Using viable, developmentally normal
transgenic mice lacking the PKG-I specifically in nociceptors with
preserved expression in spinal neurons, brain, and all other organs,
we demonstrate here that PKG-I localised in nociceptor terminals
constitutes a key mediator of synaptic LTP and that its activation is
functionally associated with pain hypersensitivity in vivo.
Results
Mice Lacking PKG-I Conditionally in a Nociceptor-Specific
Manner
Mice lacking PKG-I specifically in a primary nociceptor-specific
manner (SNS-PKG-I
2/2) were generated via Cre/loxP-mediated
recombination by mating mice carrying the floxed prkg1 allele
(PKG-I
fl/fl) [15] with a mouse line expressing Cre recombinase
under control of the Nav1.8 promoter (SNS-Cre) [16]. We have
previously demonstrated that SNS-Cre mice enable gene recom-
bination commencing at birth selectively in nociceptive (Nav1.8-
expressing) sensory neurons, without affecting gene expression in
the spinal cord, brain, or any other organs in the body [16,17]. An
anti-PKG-I antibody [18] yielded specific staining in wild-type
dorsal root ganglia (DRG), but not in those from global PKG-I
2/2
mice [19], thereby revealing Cre/loxP-mediated deletion of PKG-
I in DRG of SNS-PKG-I
2/2 mice (Figure 1A). Quantitative size-
frequency analysis revealed that a majority of DRG neurons
expressing PKG-I in wild-type mice are small-diameter neurons,
which show a near complete loss of PKG-I expression in SNS-
PKG-I
2/2 mice (Figure 1B; p,0.001). In contrast, a few large-
diameter neurons showed low levels of anti-PKG-I immunoreac-
tivity in DRGs of PKG-I
fl/fl, which was entirely retained in SNS-
PKG-I
2/2 mice (Figure 1A and B). Confocal analysis of dual
immunofluorescence experiments revealed PKG-I immunoreac-
tivity in nearly all Isolectin-B4 (IB4)-labelled non-peptidergic
nociceptors and substance P-expressing peptidergic nociceptors
in PKG-I
fl/fl mice, both of which are selectively lost in SNS-PKG-
I
2/2 mice (typical examples in Figure 1C and quantitative
summary in Figure 1D). In contrast, large-diameter neurofila-
ment-200-immunoreactive neurons entirely retained PKG-I
expression in the SNS-PKG-I
2/2 mice (Figure 1C,D). Taken
together, these results show that PKG-I is normally expressed in
nearly all nociceptors and is selectively lost from these neurons, but
not from tactile-responsive and proprioceptive DRG neurons, in
SNS-PKG-I
2/2 mice.
We found that PKG-I expression is entirely unaltered in the
brains of SNS-PKG-I
2/2 mice (an example of expression in
cerebellar purkinje neurons is shown in Figure 1E, right panel),
whereas global PKG-I
2/2 mice demonstrated a complete loss of
anti-PKG-I immunoreactivity (Figure 1E, right panel). In the
Author Summary
Pain is an important physiological function that protects
our body from harm. Pain-sensing neurons, called
nociceptors, transduce harmful stimuli into electrical
signals and transmit this information to the brain via the
spinal cord. When nociceptors are persistently activated,
such as after injury, the connections they make with
neurons in the spinal cord are altered in a process called
synaptic long-term potentiation (LTP). In this study, we
examine the molecular and cellular mechanisms of LTP at
synapses from nociceptors onto spinal neurons. We use
multiple experimental approaches in mice, from genetic to
behavioural, to show that this form of LTP involves
presynaptic events that unfold in nociceptors when they
are repetitively activated. In particular, an enzyme activat-
ed by the second messenger cGMP, referred to as Protein
Kinase G-I, phosphorylates presynaptic proteins and
increases the release of neurotransmitters from nociceptor
endings in the spinal cord. When we genetically silence
Protein Kinase G-I or block its activation in nociceptors,
inflammatory pain is markedly reduced at the behavioural
level. These results clarify basic mechanisms of patholog-
ical pain and pave the way for new therapeutic
approaches.
Presynaptic Mechanisms of Spinal Potentiation
PLoS Biology | www.plosbiology.org 2 March 2012 | Volume 10 | Issue 3 | e1001283Figure 1. Nociceptor-specific deletion of PKG-I and lack of developmental defects in SNS-PKG-I
2/2 mice. (A) Immunoreactivity for an
anti-PKG-I antibody was detected widely in DRG neurons of mice carrying floxed PKG-I alleles (PKG-I
fl/fl) and was lost either selectively in SNS-PKG-
I
2/2 mice or entirely in global PKG-I
2/2 mice. (B) Quantitative size analysis of neurons of the dorsal root ganglia (DRG) expressing PKG-I in SNS-PKG-
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2/2 mice, anti-PKG-I immunoreactiv-
ity was decreased selectively in the superficial dorsal laminae,
which represent termination zones of the nociceptive afferents, as
would be expected from SNS-Cre-mediated gene deletion in
nociceptors (Figure 1E, left panel). In contrast, neurons in the
spinal cord entirely maintained immunoreactivity for PKG-I and
appeared particularly conspicuous (arrowheads in Figure 1E, left
panel) due to the loss of PKG-I labelling in afferent terminals in
SNS-PKG-I
2/2 mice. Furthermore, anti-Cre immunohistochem-
istry as well as Western blot analysis with anti-PKG-I antibody
confirmed that SNS-PKG-I
2/2 mice show a DRG-specific loss of
PKG-I while retaining expression in the spinal cord and brain
(Figure S1).
In contrast to global PKG-I
2/2 mice, which typically
demonstrate lethality in the first few weeks of life, SNS-PKG-
I
2/2 mice were normal, fertile, and showed a normal life
expectancy. In contrast to defects reported in global PKG-I
2/2
mice [10], SNS-PKG-I
2/2 mice showed normal early targeting of
TrkA-expressing primary afferents arising from the DRG
(arrowheads in Figure 1F, upper panels) in the developing spinal
dorsal horn at embryonic day 13 (E13). Unlike global PKG-I
2/2
mice [10], SNS-PKG-I
2/2 mice did not show defects in T-
branching of DiI-labelled primary afferents in the spinal cord over
embryonic developmental stages (arrows in Figure 1F, lower
panels). Similarly, central and peripheral patterning of peptidergic
or non-peptidergic nociceptors was normal in adult SNS-PKG-I
2/2
mice, as revealed by immunostaining for substance P and binding
to IB4, respectively, in the spinal dorsal horns and skin (Figure
S2A). Because peptidergic mechanisms have been suggested to
play an important role in spinal LTP [5], we ascertained that
SNS-PKG-I
2/2 mice are not different from control mice with
respect to the abundance of substance P in the spinal circuitry.
Control and knockout mice exhibited the same prevalence of
substance P-immunoreactive cells within DRG (33%65% versus
29%63%, respectively), which were not significantly different
from each other (p.0.05, Student’s t test). Moreover, the level of
substance P immunoreactivity was similar in the superficial spinal
dorsal horn across genotypes (mean intensities in PKG-I
fl/fl mice
and SNS-PKG-I
2/2 mice were 5063a n d5 1 63 arbitrary units,
respectively). Importantly, confocal microscopy revealed normal
density of synapses between substance P-containing nociceptive
afferents and PSD-95-positive puncta (representing postsynaptic
aspects of glutamatergic synapses) in the spinal dorsal horns of
SNS-PKG-I
2/2 mice as compared to PKG-I
fl/fl mice (examples
and quantification in Figure S2B). Finally, we addressed the
internalization of NK1 receptors on spinal lamina I neurons
following peripheral nociceptive stimulation in vivo, which has
been demonstrated to be a clear indicator of nociceptive activity-
induced synaptic release of substance P [20]. As shown in Figure
S2C, application of a 52uC heat stimulus for 20 s to the plantar
paw surface led to internalization of NK1 receptors in lamina I
neurons of L3/L4 segments to a similar extent in SNS-PKG-I
2/2
and PKG-I
fl/fl mice (quantification in Figure S2D). Unlike global
PKG-I
2/2 mice [14], SNS-PKG-I
2/2 mice showed a normal
lamination of the spinal cord over early postnatal stages (Figure
S2E). Thus, the multiple developmental defects in the patterning
of sensory afferents and spinal lamination that have been
reported in global PKG-I
2/2 mice were not observed in SNS-
PKG-I
2/2 mice.
Loss of PKG-I in Presynaptic C-Fiber Terminals, But Not
Postsynaptically in Spino-PAG Neurons, Precludes
Expression of Spinal LTP without Altering Basal
Transmission or Excitability
To address activity-dependent plasticity at spinal synapses, we
recorded C-fiber-evoked synaptic LTP on spinal lamina I neurons
projecting to the periaqueductal grey (PAG), which were
retrogradely labelled upon stereotactic injection of DiI in the
PAG (the experimental scheme is shown in Figure 2A and an
example of a labelled cell is shown in Figure S3A) [5]. In spinal-
PAG projection neurons of wild-type mice, a conditioning low
frequency stimulation of 2 Hz for 2 min produced synaptic LTP of
monosynaptic C-fiber evoked EPSCs by more than 200% at
30 min (Figure 2B). LTP at these synapses was preserved in the
presence of strychnine and gabazine, which block glycinergic and
GABAergic inhibitory neurotransmission, respectively (Figure 2B).
Similar results were obtained upon using another standard blocker
of GABAergic neurotransmission, bicuculline, in combination with
strychnine (Figure S3B). Hence, LTP does not manifest due to
primary afferent depolarization mediated by presynaptic GABA
receptors or disinhibition of the postsynaptic neuron. To test
whether LTP requires a postsynaptic function of PKG-I, we
dialyzed standard PKG-I inhibitors, such as the non-permeant
peptide inhibitor RKRARKE [21,22] or KT5823 [23], into spinal
neurons via the patch pipette. These manipulations did not affect
the magnitude or duration of C-fiber-evoked LTP at spino-PAG
synapses (Figure 2C and Figure S3C), suggesting that PKG-I
localized postsynaptically in spino-PAG projection neurons does
not play a role in LTP at this synapse.
To assess the role of PKG-I localized presynaptically in spinal
nociceptor terminals, we then analysed PKG-I
fl/fl mice and SNS-
PKG-I
2/2 mice. In spinal-PAG projection neurons of PKG-I
fl/fl
mice, a conditioning low frequency stimulation of 2 Hz for 2 min
produced LTP with a magnitude of more than 200% at 30 min
and more than 300% by 60 min (typical examples of time course
and EPSC traces are given in Figure 2D,E). Prior to the
conditioning stimulus, baseline values of C-fiber-evoked EPSCs
stayed constant over the period of recording in both genotypes
(Figure 2D,E). In striking contrast to PKG-I
fl/fl mice, the
conditioning stimulus did not evoke LTP in spinal-PAG projection
neurons in SNS-PKG-I
2/2 mice (Figure 2D,E; see Figure 2F and
2G for quantitative summary at 30 min post-conditioning
stimulus; p,0.001; at least 13 neurons from each genotype were
tested).
I
2/2 mice and PKG-I
fl/fl littermates showing specific loss of PKG-I in small-diameter neurons in SNS-PKG-I
2/2 mice. Data in panels represent mean 6
S.E.M.; n=10–15 DRG sections each. (C, D) Typical examples (C) and quantitative summary (D) from dual immunofluorescence experiments showing
that in SNS-PKG-I
2/2 mice, PKG-I immunoreactivity is abrogated from nociceptors, i.e. Isolectin-B4-positive (IB4) or Substance P-positive (a-Sub P)
neurons, but retained in neurofilament 200-positive (a-NF200) large diameter neurons, in comparison with control littermates (PKG-I
fl/fl). n=10–15
DRG sections each; * p,0.001, ANOVA, post hoc Fisher’s test. (E) Typical examples of anti-PKG-I immunostaining in the brain (cerebellar Purkinje
neurons are shown) and spinal dorsal horns of SNS-PKG-I
2/2 mice, their PKG-I
fl/fl littermates, and global PKG-I
2/2 mice. Spinal dorsal horns of SNS-
PKG-I
2/2 mice showed a loss of anti-PKG-I immunoreactivity in the superficial neuropil (+), but distinct preservation of signals in cell bodies
(arrowheads). (F) Typical examples of patterning of Trk-A-expressing sensory afferents (arrowheads in upper panels) and T-branching of DiI-labelled
sensory afferents (arrows in lower panels) in the spinal cord in PKG-I
fl/fl mice and SNS-PKG-I
2/2 mice at embryonic day 13.5 (E13.5). Scale bars
represent 50 mm in panel A, 50 mm in panels A and C, 100 mm for spinal cord and 50 mm for cerebellum in panel E, and 100 mm in panel F. DRG, dorsal
root ganglia; S.C., spinal cord.
doi:10.1371/journal.pbio.1001283.g001
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address how basal nociceptive transmission at these synapses is
affected in SNS-PKG-I
2/2 mice. Analysis of EPSC magnitude
evoked by the first and the last pulse of the conditioning train
revealed short-term depression of evoked EPSCs during the
conditioning train, which was equivalent in PKG-I
fl/fl mice and
SNS-PKG-I
2/2 mice (Figure 3A; p=0.95), showing that the
conditioning stimulus was equally effective in mice from both
groups. Furthermore, basal C-fiber-evoked EPSCs were compa-
rable between PKG-I
fl/fl and SNS-PKG-I
2/2 mice. We also
established detailed input-output curves representing the relation-
ship between the intensity of dorsal root stimulation and evoked
EPSCs in the absence of a conditioning stimulus and found no
differences between PKG-I
fl/fl and SNS-PKG-I
2/2 mice
(Figure 3B; p=0.74). Furthermore, the intensity of dorsal root
stimulation required to elicit an action potential in post-synaptic
spinal-PAG projection neurons was identical in PKG-I
fl/fl and
SNS-PKG-I
2/2 mice (an example is shown in Figure 3C). The
intact nature of responsiveness in spinal-PAG projection neurons
was demonstrated by similarities in their activation profiles upon
current injection in SNS-PKG-I
2/2 mice and their PKG-I
fl/fl
littermates (an example is shown in Figure 3D). In all of the above
experiments, quantitative analyses revealed that resting membrane
potential, action potential width, delay after stimulation artefact,
action potential threshold, delay for generation of first action
potential (latency to first AP), as well as amplitude of after
hyperpolarisation (AHP) were similar in SNS-PKG-I
2/2 mice and
PKG-I
fl/fl mice (Figure 3E; p.0.05 in all cases, Student’s t test).
Finally, as an additional indicator of the number of fibers activated
during electrical stimulation, we recorded fiber volleys in input/
output measurements. Recording C-fiber volleys in the L4 and L5
dorsal roots derived from PKG-I
fl/fl and SNS-PKG-I
2/2 mice
revealed typical responses, which increased in amplitude with
increasing stimulus intensity (representative traces are shown in
Figure 3F). The amplitudes of C-fiber volley responses were not
significantly different between PKG-I
fl/fl and SNS-PKG-I
2/2
mice (stimulus-response curves are shown in Figure 3G; p.0.05;
n=16 per genotype), demonstrating directly that the number of
fibers activated upon electrical stimulation was comparable
between genotypes and could therefore not explain the failure to
evoke synaptic potentiation in SNS-PKG-I
2/2 mice. These
comprehensive analyses show that a presynaptic loss of PKG-I
was specifically linked to a failure of activity-dependent potenti-
ation of transmission at synapses between nociceptors and spinal-
PAG projection neurons, but not to modulation of basal synaptic
transmission.
Evidence for a Presynaptic Mechanism for Synaptic
Potentiation on Spinal-PAG Projection Neurons and a
Role for Presynaptic PKG-I
Following our observation that a specific presynaptic alteration
in PKG-I expression perturbed spinal LTP, we then addressed
potential contributions of presynaptic mechanisms at synapses
between nociceptors and spinal projection neurons [7,24]. By
recording miniature EPSCs in spinal-PAG projection neurons of
control mice, we observed that quantal content varies largely,
which is expected since these spinal projection neurons receive
multisynaptic inputs from primary afferents as well as spinal
interneurons. Furthermore, inputs arising from spinal interneurons
are not expected to change in SNS-PKG-I
2/2 mice since the
molecular perturbation is specific to nociceptor terminals. Thus,
the net contribution of C-fibers to the population of mEPSCs is
difficult to assess because it is unclear which fraction of mEPSCs
can be attributed to C-fibers, which then makes detection of
potentially small presynaptic changes highly unlikely when
performing mini-analysis. To study synaptic events which could
be clearly assigned to activation of presynaptic primary afferent
fibers alone, we employed a protocol of minimal stimulation,
setting the dorsal root stimulation parameters such that a synaptic
failure rate of approximately 60% was achieved in recording
solution containing 1 mM Ca
2+ and 5 mM Mg
2+. The failure rate
remained constant over a period of at least 30 min upon repetitive
test stimulation in the absence of a conditioning stimulus
(55.9%63.9% pre- and 57.1%68.1% at 30 min). However, upon
application of the conditioning stimulus, minimal stimulation using
the same parameters evoked a decrease in the frequency of
synaptic failures within a few minutes in slices derived from PKG-
I
fl/fl mice, indicating a change in the probability of neurotrans-
mitter release; decrease in synaptic failures was accompanied by a
corresponding rise in the magnitude of C-fiber-evoked EPSCs (see
Figure 4A for typical example and Figure 4C for quantitative
summary of C-fiber-evoked EPSCs recorded every 15 s; n=5;
p=0.04). In contrast, the rate of synaptic failures did not change
significantly following conditioning stimulus in slices derived from
SNS-PKG-I
2/2 mice (see Figure 4B and 4C; n=7; p=0.68).
EPSC values at the end of the recording were not significantly
elevated as compared to basal values in SNS-PKG-I
2/2 mice
(2561.7 pA before and 21.161.2 pA at 30 min after the
conditioning stimulus; p=0.14).
In analogy to studies on hippocampal circuits, although the
above evidence for a decrease in failure rate is indicative of
increased presynaptic release probability, it has also been linked to
unsilencing of silent synapses [25]. Therefore, to further
consolidate presynaptic mechanisms, we focussed on the analysis
of paired-pulse facilitation (PPF), which represents a short-lasting
increase in the second evoked EPSP when it follows shortly after
the first and is well accepted as an indication of presynaptic
mechanisms of long-term potentiation in the hippocampus [26]. In
hippocampal CA1 neurons, PPF can increase as well as decrease
in conjunction with LTP in a manner inversely proportional to the
PPF prior to the conditioning stimulus [26]. Indeed, we obtained
similar results in recordings at spinal synapses between C-fibers
and spinal-PAG projection neurons. In spinal slices derived from
mice of both genotypes, we found evidence for PPF as well as
paired-pulse depression (PPD) prior to the LTP-inducing condi-
tioning stimulus (typical traces are shown in Figure 4D). Whereas a
majority of neurons derived from PKG-I
fl/fl mice demonstrated a
clear change in PPF or PPD following conditioning stimulus,
neurons derived from SNS-PKG-I
2/2 mice did not (see examples
Figure 2. Contribution of PKG-I to synaptic long-term potentiation (LTP) at contacts between C-nociceptors and spinal-PAG
projection neurons. (A) Schematic representation of the experimental approach for dorsal root stimulation and whole-cell patch clamp recordings
from spino-PAG projection neurons in lamina I. (B, C) Synaptic LTP was observed following conditioning low-frequency stimulation (2 Hz) of dorsal
roots in wild-type mice. LTP was preserved upon spinal blockade of inhibitory neurotransmission (panel B) or upon blockade of PKG-I specifically in
the postsynaptic neuron via application of a non-permeant inhibitor in the patch pipette (panel C); n=11–19 slices each. (D–G) Representative traces
(D), time course (E), and quantitative summary of LTP (F, G) evoked by conditioning low-frequency stimulation (2 Hz) of dorsal roots in PKG-I
fl/fl mice,
but not in SNS-PKG-I
2/2 mice; n=12 slices per genotype. All data are represented as mean 6 S.E.M. * p,0.05 as compared to basal and { p,0.05 as
compared to PKG-I
fl/fl mice, ANOVA followed by post hoc Fisher’s test.
doi:10.1371/journal.pbio.1001283.g002
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PLoS Biology | www.plosbiology.org 7 March 2012 | Volume 10 | Issue 3 | e1001283in Figure 4D). We then plotted the paired-pulse ratio (PPR) of the
entire cohort of recorded neurons at 30 min after conditioning
stimulation as a function of the basal PPR recorded prior to the
conditioning stimulus (Figure 4E,F). This analysis revealed that
neurons in PKG-I
fl/fl mice with larger basal values of PPR prior to
the conditioning stimulus (indicated by filled round symbols in
Figure 4E) consistently showed a decrease in PPR after the
conditioning stimulus (Figure 4D), which is indicative of an
increase in the probability of release (PR, Figure 4E). This drop in
PPF following conditioning stimulation did not come about or was
reduced in neurons from SNS-PKG-I
2/2 mice (filled round
symbols in Figure 4F). A smaller cohort of synapses in PKG-I
fl/fl
mice showed an increase in PPF after conditioning stimulation,
but this was restricted to neurons with a low magnitude of PPF
prior to the conditioning stimulus (i.e., a PPR of about 1.1–1.2,
filled square symbols in Figure 4E) and a low expression of LTP
(Figure S4A). Again, this change was not observed in the
corresponding cohort of neurons in SNS-PKG-I
2/2 mice (filled
square symbols in Figure 4F, Figure S4B). Conversely, in PKG-I
fl/fl
mice, higher magnitudes of LTP (i.e., between 150% and 350%,
indicated by black frame in Figure S4A) wereconsistently associated
with a decrease in PPR, which is indicative of an increase in release
probability. Neither LTP nor consistent changes in PPR were
observed in SNS-PKG-I
2/2 mice (Figure S4B). In conclusion, the
failure rate analysis and PPR analysis strongly support the inference
that the expression of LTP at spino-PAG synapses comes about via
presynaptic mechanisms involving an increase in release probability
via PKG-I.
Signalling Targets of PKG-I in Nociceptors, Their
Activation upon Nociceptive Stimulation, and Their Role
in Spinal Plasticity
In an effort to understand the underlying molecular mecha-
nisms, we then addressed potential substrates for the kinase activity
of PKG-I in nociceptors. In particular, we reviewed known
substrates of PKG-I in other biological systems and focussed on
those for which we hypothesized a role in synaptic transmission.
We first set up an assay system for testing involvement of PKG-I
substrates in the DRG selectively upon persistent nociceptive
stimulation in vivo, using Vasodilator-stimulated phosphoprotein
(VASP), a classical target of PKG-I, as an indicator of PKG-I
activity [8,27]. Lysates of L4-L5 DRGs from naı ¨ve PKG-I
fl/fl and
SNS-PKG-I
2/2 mice showed comparable levels of VASP
expression (Figure S5A, basal). Within minutes after persistent
nociceptive stimulation via injection of formalin in the hindpaw,
L4-L5 DRGs from PKG-I
fl/fl mice showed a striking phosphor-
ylation of VASP at Serine 239 (typical examples in Figure S5A and
summary in Figure S5B,C; see Text S1 for details; p=0.03 as
compared to basal). This was markedly reduced in formalin-
injected SNS-PKG-I
2/2 mice (Figure S5A,B; p=0.18 as com-
pared to basal SNS-PKG-I
2/2 mice and 0.03 as compared to
formalin-injected PKG-I
fl/fl mice). These results show that
persistent activation of nociceptors leads to rapid signalling via
PKG-I in DRG neurons in vivo, which is lost in SNS-PKG-I
2/2
mice, as expected.
Using this assay system, we then addressed another key target of
PKG-I, which has been mainly studied so far mechanistically in
smooth muscle cells. Dephosphorylation of myosin light chains
(MLC) [28] via PKG-I-dependent phosphorylation and activation
of myosin light chain phosphatase in smooth muscle cells is a
decisive mechanism underlying NO-mediated vasodilation [8].
Following formalin injection in the paw, we observed a strong
phosphorylation of MLC in L4-L5 DRGs from PKG-I
fl/fl mice,
which was found to be lacking in formalin-treated SNS-PKG-I
2/2
mice (Figure 5A and 5B). These differences did not arise due to
differences in expression levels of MLC between SNS-PKG-I
2/2
mice and PKG-I
fl/fl mice (Figure 5B; Figure S5C). This finding
was unexpected because it suggests a role for PKG-I in increasing
MLC phosphorylation in DRG neurons, which is contrary to the
classical role ascribed to PKG-I in MLC dephosphorylation. We
reasoned that if our findings hold true, synthesis of cGMP ought to
be a critical intermediate step in activity-dependent MLC
phosphorylation in DRG neurons. Indeed, in mice pre-treated
with an inhibitor of the soluble guanylyl cyclase, ODQ, and a pan-
inhibitor of membrane-bound guanylyl cyclases, LY83583, via
intrathecal application, formalin-induced MLC phosphorylation
in L4-L5 DRGs was strongly reduced (see examples in Figure 5C;
quantitative summary from three experiments is given below the
Western blot). Immunohistochemistry revealed that nociceptor
activation-induced increase in MLC phosphorylation occurred in
the spinal termination zone of nociceptors (lamina I and II) as well
as in spinal neurons (Figure 5D).
Interestingly, synaptic potentiation induced by a conditioning
stimulus on spinal-PAG projection neurons was abolished in the
presence of ML-7, an inhibitor of MLCK (Figure 5E and
Figure 5F; p=0.004 as compared to vehicle-treated control slices).
Furthermore, consistent with our observations in SNS-PKG-I
2/2
mice, inhibition of MLC phosphorylation did not affect basal
transmission at this synapse (Figure 5G; p=0.761). Thus, the
PKG-I target, pMLC, is functionally linked to potentiation of
synaptic transmission in nociceptive laminae.
Ikeda et al. [5] have reported that inhibition of IP3R activation
blocks conditioning stimulus-induced synaptic potentiation at
synapses between nociceptors and spinal-PAG projection neurons.
This is particularly interesting because IP3R1 contains a PKG-I-
recognition motif at serine 1755 and has been reported to be
phosphorylated by PKG-I in vitro, putatively leading to gain of
function [29,30]. We observed that IP3R1 is indeed a target of
PKG-I in nociceptors and is functionally associated with
modulation of calcium release from intracellular stores. In
immunoprecipitation experiments from L4-L5 DRGs, formalin-
injected PKG-I
fl/fl mice demonstrated highly enhanced serine
1755 phosphorylation of IP3R1 over the basal state; this effect was
markedly reduced in DRGs obtained from formalin-injected SNS-
PKG-I
2/2 mice (Figure 6A,B), although expression levels of
IP3R1 were comparable between SNS-PKG-I
2/2 mice and PKG-
I
fl/fl mice (Figure S5D).
Figure 3. Analysis of basal neurotransmission and properties of spinal-PAG projection neurons in spinal slices derived from SNS-
PKG-I
2/2 mice and their PKG-I
fl/fl littermates. (A, B) Short-term depression during the conditioning train of low-frequency stimulation (A) and
input-output curves for basal synaptic transmission between C-fibers and spinal-PAG projections neurons (B) were not different between PKG-I
fl/fl
mice and SNS-PKG-I
2/2 mice (n=12 each). (C, D) Activation properties of spinal neurons are not altered in SNS-PKG-I
2/2 mice as compared to their
PKG-I
fl/fl littermates. Dorsal root stimulation threshold for evoking action potentials (C) in spinal-PAG projection neurons and spiking properties of
spinal-PAG projection neurons upon direct current injection (D) are similar in SNS-PKG-I
2/2 mice and their PKG-I
fl/fl littermates. (E) Resting membrane
potential (RMP), action potential (AP) properties, such as threshold, amplitude, half-width, and the latency of first AP, and amplitude of after
hyperpolarization (AHP) were similar between genotypes (p.0.05; Student’s t test). (F, G) Typical traces (F) and magnitude of C-fiber volleys in L4/L5
roots recorded at different intensities of stimulation are comparable in SNS-PKG-I
2/2 mice and their PKG-I
fl/fl littermates (n=16 each).
doi:10.1371/journal.pbio.1001283.g003
Presynaptic Mechanisms of Spinal Potentiation
PLoS Biology | www.plosbiology.org 8 March 2012 | Volume 10 | Issue 3 | e1001283Figure 4. Analysis of a presynaptic component to C-fiber-evoked LTP on spinal-PAG projection neurons. (A, B) Activation of C-
nociceptors potentiates synaptic transmission by decreasing the rate of synaptic failures via activation of presynaptic PKG-I. Shown are typical
examples of the frequency of synaptic failures (arrows) and synaptic successes (C-fiber-evoked EPSCs) evoked by minimal stimulation of dorsal roots
prior to and after application of the conditioning stimulus in PKG-I
fl/fl mice (A) and SNS-PKG-I
2/2 mice (B). (C) Summary of average failure rates upon
minimal stimulation of dorsal roots prior to and 30 min following the conditioning stimulus (n=5 slices for PKG-I
fl/fl mice and 7 slices for SNS-PKG-
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been suggested to positively modulate IP3R1 activity in heterol-
ogous test systems [30]. We observed that this function of PKG-I
indeed plays an important role in modulating calcium release from
intracellular stores in nociceptive neurons of the DRG. We
performed Fura-2-based calcium imaging on dissociated DRG
neurons derived from PKG-I
fl/fl and SNS-PKG-I
2/2 mice using
Fluro488-conjugated Isolectin B4 (IB4-Fluro488) for live identifi-
cation of small-diameter nociceptive neurons (neurons dually
labelled with Fura-2 and IB4-Fluor488 are indicated by arrow-
heads in Figure 6C). The baseline values of the Fura2 ratios
(F340/F380) were not significantly different between control mice
(1.04960.010) and SNS-PKG-I
2/2 mice (1.04060.008) (p.0.05;
Student’s t test). Stimulation of calcium release via activation of
Gq/11-phospholipase C-IP3R1 pathway by addition of ligands,
such as bradykinin (BK) and the P2Y-receptor ligand, UTP, led to
typical increases in the ratio of Fura-2 fluorescence at 340/380 nm
in neurons from PKG-I
fl/fl mice, which were markedly reduced in
neurons from SNS-PKG-I
2/2 mice (see Figure 6D for typical
examples and Figure 6E for quantitative summary; p,0.001 with
respect to BK and UTP). In contrast, Fura2-labelled neurons with
large-diameter somata, which were IB4-negative, did not show
differences in calcium responses between PKG-I
fl/fl mice and
SNS-PKG-I
2/2 mice (an example is indicated by arrow in
Figure 6C and quantitative summary is given in Figure 6E). In
contrast, rapid calcium influx caused by KCl-induced depolarisa-
tion or capsaicin-evoked influx of calcium via TRPV channels was
comparable in DRG neurons derived from SNS-PKG-I
2/2 mice
and PKG-I
fl/fl mice (Figure 6D,E; p.0.05), showing thereby that a
loss of PKG-I in nociceptive neurons is specifically linked to
defects in IP3R-mediated calcium release from intracellular stores.
Taken together, these biochemical and functional experiments
suggest that following persistent nociceptive stimulation, PKG-I
mediates potentiation of IP3R1 activity and MLC phosphorylation
in sensory neurons, which is functionally linked to synaptic LTP at
synapses between C-nociceptors and spinal-PAG projection
neurons.
A Key Functional Role for PKG-I and Its Substrates in a
Behavioural Paradigm for Spinal Sensitization in Vivo
We then went on to address whether these findings bear
relevance to pain-related behaviour in vivo and found a functional
role for PKG-I and its substrates in behavioural paradigms for
spinal sensitization. As a test system, we studied the Phase II of
formalin-induced nocifensive behavioural responses, which are
manifest at 10–60 min after intraplantar formalin injection, for
two reasons: one, this represents a widely used paradigm for
studying central changes in pain processing caused by a persistent
activation of nociceptors [31], and two, intraplantar formalin
induces synaptic LTP on spinal projection neurons with a
matching time-course [5]. Formalin-induced phase II responses
were significantly reduced upon intrathecal pretreatment with 2-
APB or ML-7 to the lumbar spinal cord (Figure 7A; p,0.01 for 2-
APB and ML-7 in comparison to vehicle control, respectively),
implicating involvement of IP3R function and MLC phosphory-
lation, respectively. Similarly, SNS-PKG-I
2/2 mice showed
markedly reduced phase II responses than PKG-I
fl/fl mice
(Figure 7B; p,0.001 as compared to PKG-I
fl/fl mice).
Preserved Basal Nociception and Reduction of Primary
Hyperalgesia in SNS-PKG-I
2/2 Mice
Basal withdrawal thresholds and response latencies to acute
application of paw pressure (e.g., as tested with a dynamic
aesthesiometer) (Figure S6A, left panel) or thermal stimuli (e.g., a
radiant infrared heat ramp) (Figure S6A, right panel), respectively,
to the paw surface were found to be similar across SNS-PKG-I
2/2
mice and their control littermates (p.0.05). Furthermore, motor
performance on a Rotarod was unaffected in SNS-PKG-I
2/2
mice (Figure S6B; p=0.20). We have previously shown in details
that SNS-Cre mice show no alterations in the processing of acute
pain or chronic inflammatory or neuropathic pain [6,32].
In the context of studying disease-induced pain hypersensitivity,
we first focussed on a model of inflammatory pain which is
associated with primary hyperalgesia in the inflamed area and
ongoing nociceptive inputs from the periphery throughout the
time of testing, namely unilateral hindpaw inflammation induced
by injection of Complete Freund’s Adjuvant (CFA) [32,33]. CFA
injection produced similar levels of edema in SNS-PKG-I
2/2 and
PKG-I
fl/fl mice (Figure S6C) and hypersensitivity to graded von
Frey mechanical stimuli (Figure 7C,D) or to plantar heat
(Figure 7E) applied to the ipsilateral paw was assessed at 6, 12,
24, 48, and 96 h thereafter. Following inflammation, PKG-I
fl/fl
mice demonstrated the characteristic leftward and upward shift in
the stimulus-response curve over basal curves reflecting mechan-
ical hypersensitivity (black squares in Figure 7C). In contrast, SNS-
PKG-I
2/2 mice demonstrated a less marked deviation from
baseline behaviour upon CFA-induced inflammation (red squares
in Figure 7C). Furthermore, the relative drop in response
thresholds to von Frey hairs (defined here as minimum force
required to elicit 40% response frequency) in the inflamed state
over basal (pre-CFA) state occurred to a significantly lesser extent
in SNS-PKG-I
2/2 mice as compared to PKG-I
fl/fl mice (left panel
in Figure 7D; p,0.05 at all time points tested). Finally, SNS-PKG-
I
2/2 mice showed a significantly lower magnitude of thermal
hyperalgesia than PKG-I
fl/fl mice at 6 h after CFA and did not
show hyperalgesia at all from 12 h onwards after CFA injection,
whereas PKG-I
fl/fl mice continued to show thermal hyperalgesia
all the way up to the latest time point tested, namely 96 h
following CFA injection (Figure 7E; p,0.01 between PKG-I
fl/fl
and SNS-PKG-I
2/2 mice at all time points tested). We infer from
the above that the development of primary hyperalgesia and
mechanical allodynia following somatic inflammation is impaired
by a loss of PKG-I in nociceptors.
Although perturbation of spinal LTP may have contributed to
the above phenotype in SNS-PKG-I
2/2 mice, it is conceivable
that a peripheral role for PKG-I in nociceptors may at least
partially account for changes in primary hyperalgesia. To address
functional changes in nociceptor sensitivity in the inflamed tissue,
I
2/2 mice). (D–F) Analysis of paired-pulse facilitation (PPF) and paired-pulse depression (PPD) of C-fiber-evoked EPSCs induced by pairs of stimuli at
inter-stimulus interval of 110 ms in spino-PAG projection neurons from PKG-I
fl/fl and SNS-PKG-I
2/2 mice. Traces of typical recordings showing PPF or
PPD prior to (basal) and at 30 min following low-frequency conditioning stimulation of C-fibers (LFS) are shown in panel D. Paired-pulse ratios (PPR)
prior to and at 30 min after conditioning stimulation are plotted in panel E (PKG-I
fl/fl mice) and panel F (SNS-PKG-I
2/2 mice). Values of PPR above and
below 1 prior to conditioning stimulation are represented as PPF (pink field) and PPD (blue field), respectively. Note that in PKG-I
fl/fl mice, neurons
showing low initial PPF show an increase in PPF after conditioning stimulation, whereas neurons showing an initial high PPF show a decrease in PPF
following conditioning stimulation, which corresponds to an increase in probability of release. These changes are reduced or do not come about in
SNS-PKG-I
2/2 mice. All data are represented as mean 6 S.E.M. * p,0.05, ANOVA of random measures followed by post hoc Fisher’s test.
doi:10.1371/journal.pbio.1001283.g004
Presynaptic Mechanisms of Spinal Potentiation
PLoS Biology | www.plosbiology.org 10 March 2012 | Volume 10 | Issue 3 | e1001283Figure 5. Nociceptive activity-driven, PKG-I-dependent phosphorylation of myosin light chains (MLC) in DRG in vivo and its
contribution to synaptic potentiation at contacts between C-nociceptors and spinal-PAG projection neurons. (A, B) A typical example
(A) and quantitative summary (B) of levels of phosphorylated MLC in L4-L5 DRGs of SNS-PKG-I
2/2 mice and PKG-I
fl/fl littermates in the naı ¨ve state or
following formalin injection in the hindpaws. (C) Formalin-induced increase in MLC phosphorylation in L4-L5 DRGs is reduced in wild type mice
treated with inhibitors of cGMP synthesis, ODQ (25 mg/kg body weight), and LY83583 (12.5 mg/kg body weight). Mean values from three
experiments are depicted below the representative Western blot. (D) Photomicrographic images showing an increase in immunoreactivity for
phosphorylated myosin light chains in the spinal dorsal horns in wild-type mice following injection of formalin in the hindpaw. Note increased
staining in superficial neuropil as well as cell bodies. Scale bars=100 mm. (E, F) Time-course (E) and quantitative summary at 30 min (F) after the
conditioning stimulus of the blockade of spinal synaptic potentiation by ML-7, an inhibitor of myosin light chain kinase (MLCK) (n=8 slices/group).
(G) MLCK blockade does not significantly affect basal transmission upon dorsal root stimulation (3 mA).
doi:10.1371/journal.pbio.1001283.g005
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PLoS Biology | www.plosbiology.org 11 March 2012 | Volume 10 | Issue 3 | e1001283Figure 6. PKG-I mediates nociceptive activity-dependent phosphorylation of Inositol 1,4,5-triphosphate receptor 1 (IP3R1) in DRG
and potentiates evoked calcium transients. (A, B) Typical examples (A) and quantitative summary (B) of levels of immunoprecipitated IP3R1
phosphorylated at serine 1755 or total IP3R1 in L4-L5 DRG lysates derived from naı ¨ve or formalin-injected PKG-I
fl/fl and SNS-PKG-I
2/2 mice. (C–E)
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electrophysiological properties of identified polymodal C-fibres
and Ad-mechanoceptors (AM) in the saphenous nerve. The
excitability of mechanoreceptive C-fibers and AM-fibers showed a
small, but significant, increase following paw inflammation in
PKG-I
fl/fl mice (see Figure 7F for typical examples), but not in
SNS-PKG-I
2/2 mice (Figure 7F). These data indicate defects in
the development of peripheral sensitization in nociceptors of SNS-
PKG-I
2/2 mice, which could contribute to a reduction in primary
hyperalgesia; however, they are unlikely to account for the marked
defects in mechanical allodynia observed following inflammation
in SNS-PKG-I
2/2 mice.
Models of Subacute and Chronic Central Hypersensitivity,
Which Are Independent of Ongoing Input from
Peripheral Nociceptors
To explore central contributions, we utilised two models of
aberrant pain which are triggered initially by peripheral inputs but
do not require ongoing nociceptor activity in the periphery for
maintenance. For example, capsaicin injection in the skin activates
C-fibers and evokes hyperalgesia in the area of the flare (primary
hyperalegsia) as well as outside of the flare (secondary hyperalge-
sia). In PKG-I
fl/fl mice, we observed that injection of capsaicin in
the skin of the lower thigh produced a marked allodynia at the
hindpaw plantar surface, which was clearly excluded from the area
capsaicin-induced flare (see shift in von Frey response frequency in
Figure 8A; black symbols). SNS-PGK-I
2/2 mice showed mark-
edly reduced secondary hypersensitivity with capsaicin as
compared to PKG-I
fl/fl mice (red symbols in Figure 8A).
Moreover, a capsaicin-induced drop in mechanical threshold
(allodynia) was markedly reduced in SNS-PGK-I
2/2 mice as
compared to PKG-I
fl/fl mice (Figure 8B). It is well accepted that
capsaicin-induced secondary mechanical hypersensitivity reflects
C-fiber-evoked central amplification processes and can last for
several hours, long after nociceptor responses to capsaicin have
ceased owing to desensitisation of TRP channels [35]. Neverthe-
less, to rule out a potential contribution of ongoing peripheral
inputs to the above-described phenotypic differences, we per-
formed experiments in which nerve conduction was blocked with
lidocaine in the peripheral dermatome in which capsaicin was
injected in wild-type mice. As expected, lidocaine-induced nerve
blockade prior to capsaicin injection blocked the induction of
capsaicin-induced mechanical hypersensitivity (Figure 8C); in
contrast, when lidocaine was injected 15 min after capsaicin,
mechanical hypersensitivity developed normally (Figure 8C),
indicating that beyond the initial trigger, capsaicin-induced
mechanical hypersensitivity is independent of ongoing input from
peripheral nociceptors. In further experiments, we addressed the
peripheral and central contributions of PKG-I. Pharmacological
inhibition of PKG-I with KT5823 injected prior to injection of
capsaicin in the same dermatome in wild-type mice did not block
the development of capsaicin-induced mechanical hypersensitivity
(Figure 8D); in contrast, when KT5823 was injected intrathecally
prior to peripheral capsaicin injection, the induction of mechanical
hypersensitivity was markedly inhibited (Figure 8E), indicating a
role for central PKG-I, but not peripherally expressed PKG-I. To
further delineate the origin of the central (spinal) locus of PKG-I
function, we undertook similar experiments in PKG-I
fl/fl mice and
SNS-PGK-I
2/2 mice. Interestingly, intrathecally administered
PKG-I inhibitor blocked the development of capsaicin-induced
mechanical hypersensitivity in PKG-I
fl/fl mice and did not lower
mechanical sensitivity any further in SNS-PGK-I
2/2 mice
(Figure 8F), demonstrating thereby the presynaptic locus of its
action.
In the muscle pain model by Sluka and colleagues [36], two
consecutive injections of dilute acidic saline in the flank muscle
lead to secondary mechanical hypersensitivity in the ipsilateral and
contralateral paws, which lasts for several weeks. The initial
peripheral insult (i.e., flank muscle) is spatially distinct from the
area of application of nociceptive stimuli (paw surface), ruling out
a contribution of peripheral paw sensitization to the behavioural
phenotype. Secondly, it has been shown in details previously that
the secondary hyperalgesia in the paw lasts for several months
after muscle injection, is not associated with any persistent
inflammation or injury to the muscle tissue, is independent of
peripheral inputs, and is thus central in origin [36]. Upon testing
at 24 h after the induction of muscle pain, PKG-I
fl/fl mice
demonstrated a pronounced leftward and upward shift in the
stimulus-response curve to von Frey hairs applied to the plantar
paw surface (black squares in Figure 9A, middle panel), which was
still evident 3 wk later in the ipsilateral (Figure 9A, right panel);
this changes come about in the paw ipsilateral to the injected flank
muscle (upper panels in Figure 9A) as well as in the contralateral
paw (lower panels in Figure 9A). In contrast, SNS-PKG-I
2/2 mice
did not show significant deviations (red squares in Figure 9A).
Analysis of paw-withdrawal thresholds to graded pressure also
consistently revealed that muscle injection-induced drop in paw
mechanical thresholds at the paws was significantly lesser in SNS-
PKG-I
2/2 mice than in control littermates at all time points tested
(Figure 9B). In conclusion, these analyses support an essential role
for presynaptic PKG-I in nociceptor terminals in central
mechanisms of secondary mechanical hypersensitivity.
Signalling Pathways Upstream of PKG-I Activation in
Spinal Nociceptive Circuits
Finally, we asked whether PKG-I expressed in nociceptors
constitutes an important target of the NMDA-NOS-cGMP
pathway. Consistent with previous studies [37], intrathecally
administered NMDA produced a rapid facilitation of the paw
withdrawal reflex (Figure 10A). Importantly, in striking contrast to
PKG-I
fl/fl mice (black symbols), SNS-PKG-I
2/2 mice completely
failed to develop hyperalgesia following intrathecal NMDA
delivery (red symbols, upper panel in Figure 10A). Similar results
were obtained upon delivery of an NO donor, NOC-12, to the
spinal cord via intrathecal catheters (upper panel in Figure 10B).
Furthermore, intrathecal delivery of NMDA and NOC-12
produced a facilitation of the tail flick reflex in PKG-I
fl/fl mice,
but not in SNS-PKG-I
2/2 mice (lower panels in Figure 10A,B),
Comparison of evoked calcium transients in DRG neurons in culture derived from SNS-PKG-I
2/2 mice or their control PKG-I
fl/fl littermates. (c) Typical
examples of Fura2-loaded dissociated DRG neurons, which were co-stained with Fluor 488-conjugated isolectin B4 (IB4) to identify non-peptidergic
nociceptive neurons (arrowheads). (D) Typical examples of traces of calcium transients evoked by bath application of bradykinin (BK, 50 nM), UTP
(100 mM), KCl (25 mM), and capsaicin (1 mM) in IB4- and Fura2-double-labelled DRG neurons from PKG-I
fl/fl and SNS-PKG-I
2/2 mice. (E) Ratiometric
Fura2-based imaging of calcium released upon bath application of bradykinin (BK, 50 nM), UTP (100 mM), KCl (25 mM), and capsaicin (1 mM) in IB4-
and Fura2-double-labelled nociceptive DRG neurons from PKG-I
fl/fl and SNS-PKG-I
2/2 mice (9–10 independent culture experiments). Note that UTP-
induced transients in non-nociceptive large-diameter neurons (e.g., arrow in panel C) are not different across genotypes. * p,0.05, ANOVA of random
measures followed by post hoc Fisher’s test. Scale bar represents 20 mm in panel C.
doi:10.1371/journal.pbio.1001283.g006
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nociceptive functions of the NMDA and NO.
Because soluble guanylyl cyclases (sGC) represent a key
molecular link between NO and activation of PKG-I, the above
results imply that NO activates sGC in spinal presynaptic
terminals of nociceptors. While some studies report a lack of
sGC expression in DRG neurons [38], others reported expression
in a population of small diameter DRG neurons and in primary
afferents [39,40]. Here, we carried out mRNA in situ hybridisation
using riboprobes recognising the beta subunit of sGC on mouse
DRG sections and observed distinct, specific signals over the soma
of several large and small-diameter DRG neurons (arrowheads
and arrows in Figure 10C, respectively). Furthermore, the satellite
cells surrounding DRG neurons showed dense signals (red arrows
in Figure 10C). Sense control probes did not yield any appreciable
signals (Figure 10C). These results indicate that sGC mRNA is
expressed in sensory neurons of the DRG.
In addition to sGC enzymes, which are directly activated upon
NO, the membrane-bound guanylyl cyclases (mGC; Npr family)
also contribute to cGMP production in some organs (e.g., in the
cardiovascular system) [41]. Stimulated by recent reports on
expression of mGCs in DRG neurons [42], we administered a
cocktail of natriuretic peptides (ANP, BNP, and CNP) intrathecally
and observed marked hyperalgesia within 15 min after delivery,
which lasted for about 45–50 min in wild-type mice (unpublished
data) and PKG-I
fl/fl mice (Figure 10D). Interestingly, natriuretic
peptide-induced hyperalgesia was also entirely abrogated in SNS-
PKG-I
2/2 mice (Figure 10D). These results suggest that the
NMDA-NOS-soluble guanylyl cyclase-cGMP pathway as well as
the natriuretic peptide-mGC-cGMP pathways converge upon
PKG-I expressed in spinal terminals of nociceptors to modulate
nociceptive processing in the spinal cord.
Reinstating PKG-I Expression in DRG Neurons of SNS-
PKG-I
2/2 Mice Restores Mechanical Hypersensitivity
Finally, we undertook experiments to test whether PKG-I
expression alone or some downstream factor perturbed by an early
loss of PKG-I is responsible for the deficits in pain hypersensitivity
in SNS-PKG-I
2/2 mice. We constructed chimeric Adeno-
associated virions of the serotypes AAV1 and AAV2 expressing
an C-terminally GFP-tagged version of the murine PKG-I cDNA
[43]. Injection in unilateral L3 and L4 DRGs in vivo led to a
broad expression in the DRG. AAV1/2 chimeric virions
expressing GFP alone served as controls. PKG-I
fl/fl mice and
SNS-PKG-I
2/2 mice expressing GFP-tagged PKG-I or GFP
alone showed normal basal sensitivity to graded von Frey stimuli
(Figure 11B). Upon peripheral injection of capsaicin, PKG-I
fl/fl
mice expressing GFP-tagged PKG-I showed a small increase in
mechanical hypersensitivity than PKG-I
fl/fl mice expressing GFP,
which was only statistically significant at some intensities of
mechanical stimuli (Figure 11C). As expected, SNS-PKG-I
2/2
mice overexpressing GFP in DRG showed markedly reduced
mechanical hypersensitivity with capsaicin than PKG-I
fl/fl mice
overexpressing GFP. Importantly, overexpression of GFP-
tagged PKG-I fully restored mechanical hypersensitivity in
SNS-PKG-I
2/2 mice (Figure 11D). This indicates that expres-
sion of PKG-I is both necessary and sufficient for inducing
centrally maintained hypersensitivity upon persistent peripheral
activation of C-fibers.
Discussion
In contrast to the intensively studied forms of LTP in the
hippocampus, very few studies have addressed cellular and
molecular mechanisms of LTP at spinal synapses regulating the
flow of nociceptive information from the periphery towards the
brain [7,24]. Here we observed that nociceptive activity-driven
LTP at synapses between nociceptive terminals and spinal neurons
projecting nociceptive inputs to the PAG requires presynaptic
mechanisms for its full expression. Furthermore, our results
indicate that this function is mediated by cGMP acting via
PKG-I. We base our inferences on three main observations: (1) A
specific loss of PKG-I in presynaptic, but not post-synaptic,
compartments of this synapse abolished C-fiber-evoked LTP
without altering basal neurotransmission at this synapse; (2) LTP
was temporally accompanied by a decrease in the rate of synaptic
failures in a presynaptic-PKG-I-dependent manner; and (3) LTP
was associated with a change in the PPR, which did not take place
when PKG-I was deleted presynaptically in nociceptor terminals.
Importantly, higher magnitudes of LTP were consistently
associated with a decrease in PPF, and thereby with an increase
in release probability.
Previous studies have shown that the NMDA receptor-NO-
cGMP pathway is important in the induction of spinal LTP [4,5],
and it has been assumed that this pathway comes into play in the
post-synaptic compartment. However, all of the above signal
transducers are also expressed presynaptically in afferent terminals
in the spinal dorsal horn [44]. Thus, pre- and post-synaptic
contributions to spinal LTP have not been worked out so far.
There is evidence for a requirement for post-synaptic Ca
2+ change
for the induction of the LTP (i.e., in experiments with BAPTA in
recording pipette; [5]). Taken together with our results, this
suggests that a calcium-dependent postsynaptic mechanism may
be required for the induction of LTP (e.g., via NMDA receptor-
dependent generation of NO); in contrast, a presynaptic change
involving cGMP- and PKG-I-dependent increase in neurotrans-
Figure 7. Presynaptic PKG-I and molecular mediators of spinal synaptic potentiation are required for behavioural manifestation of
nociceptive hypersensitivity. (A, B) Nociceptive hypersensitivity in the intraplantar formalin test (phase II) is significantly reduced upon intrathecal
delivery of an IP3R blocker (2-APB) or an inhibitor of MLC phosphorylation (ML-7) in wild-type mice (A). SNS-PKG-I
2/2 mice show significantly reduced
formalin responses than PKG-I
fl/fl littermates (B). (C) Comparison of response frequency to von Frey hairs in SNS-PKG-I
2/2 mice (n=10; red squares)
and PKG-I
fl/fl mice (n=10; black squares) prior to and at 12 h and 24 h following unilateral hindpaw inflammation caused by intraplantar injection of
Complete Freund’s adjuvant (CFA). Note that leftward deviations in stimulus-response curves in the inflamed state over the basal state are much less
pronounced in SNS-PKG-I
2/2 mice as compared with their control PKG-I
fl/fl littermates. (D, E) Magnitude and time-course of mechanical
hypersensitivity to plantar von Frey hair application (panel D) and thermal hyperalgesia to radiant heat (panel E) following unilateral hindpaw
inflammation caused by intraplantar injection of Complete Freund’s adjuvant (CFA) to SNS-PKG-I
2/2 and PKG-I
fl/fl mice are shown. * p,0.05 as
compared to PKG-I
fl/fl mice, { p,0.05 in PKG-I
fl/fl mice or in SNS-PKG-I
2/2 mice as compared to their own basal values, and ANOVA of random
measures followed by post hoc Fisher’s test. (F) Analysis of excitability of peripheral nociceptors in PKG-I
fl/fl mice and SNS-PKG-I
2/2 mice.
Electrophysiological recordings from C-mechanoceptors (n=49) and A-d-type mechanoceptors (AM, n=43) in the paw skin-saphenous nerve
preparation derived from the paws of PKG-I
fl/fl mice revealed an inflammation-induced increase in the frequency of firing evoked by application of
pressure via a nanomotor (expressed in terms of displacement). * indicates significant statistical difference (p,0.05, ANOVA, post hoc Fisher’s test).
Similar recordings in inflamed paw skin derived from SNS-PKG-I
2/2 mice showed no significant changes between response properties of C-fibers
(n=43 fibers) and AM-fibers as compared to control SNS-PKG-I
2/2 mice (n=43 fibers).
doi:10.1371/journal.pbio.1001283.g007
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between nociceptors and spinal-PAG projection neurons.
Mechanistically, this may come about via involvement of
multiple phosphorylation targets of PKG-I. While some targets
have been identified in heterologous systems, very little is known
about the nature and functional role of PKG-I targets in vivo.
Here, we identified and validated two primary targets in DRG
neurons, namely the IP3R1 and MLC, and observed that PKG-I
modulates intracellular calcium release as well as MLC phosphor-
ylation differently in DRG neurons as compared to other
biological systems, such as the smooth muscle. For example, in
some biological systems, PKG-I has been reported to negatively
modulate calcium signals via its interaction with IRAG [18].
However, IRAG interacts selectively with the beta-isoform of
PKG-I, which is barely expressed in the DRG, but not with PKG-
I-alpha, the predominant form found in DRG neurons [10].
Furthermore, our observations that PKG-I potentiates calcium
release induced by typical mediators of nociceptive sensitization,
such as bradykinin, in identified nociceptive neurons and that
repetitive activation of nociceptors in vivo leads to PKG-I-
mediated phosphorylation of IP3R1 at serine 1755, a site
associated with positive functional modulation, implicate PKG-I
as a positive modulator of calcium signalling in nociceptive
neurons. In light of electrophysiological analyses reported here,
this raises the possibility that calcium released from IP3R1-gated
stores may participate in modulating presynaptic function.
Although a few studies at hippocampal synapses have proposed
an involvement of calcium stores in modulation of presynaptic
release [45,46], underlying cellular mechanisms are not known.
Results of this study suggest that activation of presynaptic PKG-I
may constitute the molecular link between synaptic activity and
the elevation of resting levels of calcium in presynaptic terminals,
thereby potentiating synaptic transmission via an increase in
release probability. Furthermore, we observed that MLC was
phosphorylated in a nociceptive activity-dependent manner and
that PKG-I is required for MLC phosphorylation in the DRG.
Although our electrophysiological data implicate phosphorylated
MLC in LTP at spinal synapses, not much can be inferred about
downstream mechanisms at this stage. At central synapses, MLC
phosphorylation was initially implicated in vesicle transport and in
regulation of vesicular pools [47]; however, these inferences could
not be corroborated in detailed subsequent analyses [48]. Taken
together, more detailed analyses overcoming current technical
hindrances in studying mobilization of vesicular pools in the
complex circuitry of the DRG and spinal dorsal horn will be
required to understand mechanisms underlying PKG-I-mediated
modulation of release probability at this synapse.
The possibility of functionally linking synaptic changes de-
scribed here to changes in nociceptive behaviour simultaneously
represents a good opportunity and a major challenge. As the first
parameter to test this relationship, we focused on the phase II
responses in the intraplantar formalin test, which has been
attributed to spinal nociceptive sensitization triggered by an initial
barrage of C-fiber inputs [31]. Indeed, we observed that
presynaptic loss of PKG-I as well as functional perturbation of
MLCK and IP3R, its substrates involved in LTP, inhibited phase
II behavioural responses. However, a contribution of central
mechanisms could not be inferred from the formalin data due to
several reasons: Although MLCK/IP3R inhibitors were adminis-
tered spinally, the genetically induced loss of PKG-I in SNS mice
occurred throughout the nociceptor, including peripheral termi-
nals. Moreover, there is still some ongoing activation of peripheral
nociceptors in the phase II of the formalin response [31]. Indeed,
our electrophysiological analyses in the CFA inflammatory pain
model suggested that peripheral PKG-I may contribute to primary
hyperalgesia.
Therefore, we focused on pain models in which nociceptive
hypersensitivity is triggered by peripheral nociceptors, but
maintained via central mechanisms that outlast and are indepen-
dent of peripheral inputs. One of these is the chronic muscle pain
model in which injections of dilute acidic saline in the
gastronemius muscle evokes a long-lasting secondary mechanical
hyperalgesia in the ipsilateral and contralateral paws, which lasts
for several weeks, is unrelated to muscle damage and is not
maintained by continued primary afferent input from the site of
injury, as shown by experiments involving dorsal rhizotomy and
lidocaine injections in the muscle [36]. Similarly, we addressed
capsaicin-induced secondary mechanical hyperalgesia outside of
the primary flare, which albeit triggered by C-fiber inputs, is
maintained via mechanisms of central origin as indicated by
previous studies [35] and our analyses. In both models, we found
marked defects in central hypersensitivity in SNS-PKG-I
2/2 mice.
Our results indicated that capsaicin-evoked mechanical hypersen-
sitivity is neither dependent on peripheral PKG-I function nor
does it require ongoing peripheral nociceptor sensitisation.
Moreover, they revealed that PKG-I expressed in central
terminals of nociceptors plays a decisive role in the induction of
mechanical hypersensitivity after persistent C-fiber stimulation via
capsaicin. Finally, reinstating PKG-I expression in the DRG in
adult SNS-PKG mice fully restored capsaicin-evoked mechanical
hypersensitivity, indicating that PKG-I directly, and not some
factor affected by a genetic loss of PKG-I, is a functional
determinant of C-fiber-evoked mechanical hypersensitivity.
In summary, this study shows that PKG-I expressed in
nociceptors terminals is the principal target of cGMP at
nociceptive synapses. Furthermore, it suggests that PKG-I-
mediated presynaptic facilitation and LTP in spinal projection
neurons is functionally involved in activity-dependent centrally
mediated nociceptive hypersensitivity.
Figure 8. Development of secondary mechanical hypersensitivity evoked by capsaicin is reduced upon a nociceptor-specific loss of
PKG-I via a centrally mediated mechanism involving presynaptic PKG-I. (A, B) Secondary hyperalgesia and allodynia to von Frey hairs
applied to the plantar surface of the paw, which lies outside of the flare evoked by capsaicin injected into the flank, develop to a much lesser extent
in SNS-PKG-I
2/2 mice (red squares, n=6) than in PKG-I
fl/fl mice (black squares, n=6). Shown are stimulus-response curves (A) and the summary of
response thresholds to von Frey hair application to the paw prior to and at 15 min following capsaicin injection (B). All data points represent mean 6
S.E.M. { and * indicate significant statistical difference as compared to basal state or PKG-I
fl/fl mice, respectively. (C) Peripheral nerve blockade with
lidocaine inhibits capsaicin-induced mechanical hypersensitivity in wild-type mice when lidocaine is injected prior to capsaicin, but not when
lidocaine is injected at 15 min after capsaicin, indicating that capsaicin-induced mechanical hypersensitivity is independent of on-going input from
peripheral nociceptors; n=6 mice per group. (D, E) Pharmacological inhibition of PKG-I with KT5823 in wild-type mice inhibits capsaicin-induced
mechanical hypersensitivity when KT5823 is injected intrathecally (panel E), but not when it was injected peripherally (panel D), prior to capsaicin
indicating a role for central, but not peripherally expressed, PKG-I; n=6 mice per group. (F) Inhibition of capsaicin-induced mechanical
hypersensitivity by intrathecally injected KT5823 comes about in PKG-I
fl/fl mice, but not in SNS-PKG-I
2/2 mice, indicating a specific involvement of
PKG-I expressed in central nociceptor terminals; n=6 mice per group. * p,0.05 as compared to the vehicle group in panels C–E and vehicle-treated
PKG-I
fl/fl mice in panel F. ANOVA, followed by post hoc Fisher’s test.
doi:10.1371/journal.pbio.1001283.g008
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Additional details on methods are provided in Text S1.
Genetically Modified Mice
Homozygous mice carrying the flox allele of the mouse prkg1
gene, which encodes the cGMP dependent kinase 1 (PKG-I
fl/fl)
[15], have been described previously in detail. PKG-I
fl/fl mice
were crossed with SNS-Cre mice [16] to obtain PKG-I
fl/fl;SNS-
Cre
+ mice (referred to as SNS-PKG-I
2/2 mice in this article) and
PKG-I
fl/fl mice (control littermates). Mice were crossed into the
C57BL6 background for more than 8 generations. Mice lacking
PKG-I globally (PKG-I
2/2 mice) have been described before.
Only littermates were used in all experiments to control for
background effects.
Spinal Cord Slice Preparation and Patch-Clamp
Recordings
Mice (14–18 d old) were anesthetized with a mixture of
Dormitor, Dormicum, and Fentanyl, and stereotactic injections
of DiI into the PAG were carried out (see Text S1 for details).
After 2 to 3 d, transverse 350–450 mm thick spinal cord slices with
dorsal roots attached were obtained and whole cell patch clamp
recordings of identified DiI-positive neurons were performed as
Figure 9. Centrally mediated bilateral plantar hypersensitivity in a model of chronic muscle pain which is independent of
continuous peripheral input, is reduced upon a nociceptor-specific loss of PKG-I. (A) Increase in response frequency to plantar application
of von Frey filaments at 24 h or 3 wk (3 w) following injection of acidic saline in the flank muscle is significantly more in PKG-I
fl/fl mice (n=7; black
squares) than in SNS-PKG-I
2/2 mice (n=8; red squares) in paws both ipsilateral and contralateral to the injected flank muscle. (B) Summary of
response thresholds (defined as a force eliciting a response frequency of at least 40%) to von Frey hair application to the ipsilateral or contralateral
paws, prior to and at 24 h, 72 h, and 1, 2, and 3 wk following acidic saline-induced muscle injury in SNS-PKG-I
2/2 and PKG-I
fl/fl mice. All data points
represent mean 6 S.E.M. { and * indicate significant statistical difference (p,0.05, ANOVA, post hoc Fisher’s test) as compared to basal state or PKG-
I
fl/fl mice, respectively.
doi:10.1371/journal.pbio.1001283.g009
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weregiven at 30 s intervalsto the dorsalroot via a suction electrode.
For studying the site of expression of synaptic potentiation, we used
minimal stimulation in conditions of low release probability (in mM:
NaCl 127; KCl, 1.8; KH2PO4, 1.2; Ca
2+ 1.0; Mg
2+, 5; NaHCO3,
26; glucose, 15; oxygenated with 95% O2,5 %C O 2; pH 7.4).
Dorsal root was stimulated at intensity of threshold to evoke EPSCs
on DiI-labelled spino-PAG projection neuron. Under these
conditions, the failure rate was 60.9%66.3% (n=10). To induce
synaptic potentiation, low frequency stimulation (conditioning
stimulus, 2 Hz for 2 min) was applied to dorsal root as a
conditioning stimulus with the same intensity as the test stimulus
[5]. The recording mode during conditioning stimulation was the
same as that before and after conditioning stimulation. Neurons are
voltage clamped at 270 mV. Because a suction electrode was
utilized to stimulate the whole root, a suprathreshold stimulus was
required to fully recruit C-fibers in the root [5]. Synaptic strength
was quantified by assessing the peak amplitudes of EPSCs. The
mean amplitude of 4–5 EPSCs evoked by test stimuli prior to
conditioning stimulation served as a control. Significant changes
from controlwereassessed by measuring the peak amplitudes of five
consecutive EPSCs every 5 min after conditioning stimulation.
Additional details are given in Text S1. In some experiments,
blockers of inhibitory neurotransmission, such as Gabazine (10 mM)
and Strychnine (1 mM), were added to the bath.
In a subset of animals, paired-pulse stimuli with an inter-
stimulus interval of 110 ms (0.1 ms pulse duration, 3 mA intensity,
every 30 s) were used (see Text S1 for details). Paired-pulse ratio
(facilitation or depression) of C-fiber-evoked EPSC was calculated
as the amplitude of the second C-eEPSC divided by that of the
first C-eEPSC in a pair. In a subset of experiments, PKG-I
inhibitors such as KT5823 (10 mM) or RKRARKE (250 mM) were
infused post-synaptically via the patch pipette.
Antibodies
The following antibodies were used for Western blots and
biochemical analyses: anti-IP3R1, anti-pS
1755 IP3R1 (kind gift
from Prof. Richard Wojcikiewicz), anti-VASP (Alexis Biochemi-
cal), anti-MLC, anti-alpha tubulin (Sigma), anti-pSer
239 VASP,
anti-pThr
18/pSer
19 MLC (Cell Signaling technology), anti-PKG-I
antibody [18], secondary HRP labelled anti-rabbit (Sigma
Aldrich), or anti-mouse (GK Healthcare UK Ltd.).
The following antibodies were used for immunohistochemistry:
phospho-ERK1/2 antibody (Cell signalling), anti-Fos antibody
(Chemicon), anti-Isolectin B4 antibody (vector laboratories), anti-
Calcitonin gene related peptide antibody (Immunostar), anti-
Neurofilament 200 antibody (Chemicon), anti-Substance P anti-
body (Chemicon), anti-PKG-I antibody [18], anti-PSD-95 antibody
(a gift from M. Watanabe) and anti-TrkA antibody (a kind gift from
Prof. L. F. Reichardt), and anti-cre antibody (Novagen).
Application of Drugs in Vivo
The soluble guanylyl cyclase inhibitor, ODQ (25 mg/kg body
weight; sigma Aldrich), and the membrane guanylyl cyclase
inhibitor, LY83583 (12.5 mg/kg body weight; sigma Aldrich),
were dissolved in 50% DMSO and injected in a volume of 250 ml
intraperitoneally. The following drugs were administered intra-
thecally in vivo: an inhibitor of MLCK (ML-7; 15 nmol Alexis
Biochemical, dissolved in 5% DMSO), an inhibitor of IP3R (2-
APB; 2 nmol; Calbiochem), NMDA (100 fmol; Sigma Aldrich),
the NO donor, NOC-12 (17 nmol; Sigma Aldrich), atrial
natriuretic peptide, brain natriuretic peptide and c-type natriuretic
peptide (rANP1-28, mBNP45, and hCNP1-22; 330 pmol of each
natriuretic peptide; American peptide company, Inc., USA), and
the PKG-I inhibitor KT5283 (200 pmoles). See Text S1 for details
on intrathecal delivery. Mice were allowed to recover for 2 d after
surgery, and only animals showing complete lack of motor
abnormalities were used for further experiments. 5 ml of drugs
were applied followed by flushing of the catheter with 10 mlo f
0.9% saline. The following drugs were administered peripherally
in the vicinity of the paw in experiments pertaining to capsaicin-
induced mechanical hypersensitivity: KT5823 (200 pmoles) and
lidocaine (10 ml of 2%).
Skin-Nerve Preparation and Recordings from Peripheral
Nociceptors
A total of 17 PKG-I
fl/fl and 15 SNS-PKG-I
2/2 mice were used
in the electrophysiological recordings of nerve activity. An ex vivo
skin-nerve preparation was used to study the properties of
mechanosensitive C- and A-d afferent fibres which innervate the
skin in the inflamed area 24 h following CFA inoculation (20 ml) as
described previously (see Text S1 for details).
Nociceptive Tests and Mouse Models of Pain
All animal use procedures were in accordance with ethical
guidelines imposed by the local governing body (Regierungspra ¨-
sidium Karlsruhe, Germany). All behavioural measurements were
done in awake, unrestrained, age-matched mice of both sexes that
were more than 3 mo old by individuals who were blinded to the
genotype of the mice being analyzed (see Text S1 for details).
Viral-Mediated Expression in DRG in Vivo
The open reading frame of mouse PKG-I fused C-terminally
with GFP [43] or EGFP alone was cloned in an AAV expression
construct, and chimeric AAV1/2 virions were generated using
standard protocols. Virions were diluted 1:2 with 20% mannitol
and injected unilaterally into L3 and L4 DRGs (1 ml per DRG, or
approx. 10
7 transfection units per DRG) in deeply anesthetized
mice as described in detail previously [49]. Mice were tested in
behavioural tests 2 wk after injection. At the end of the
experiment, mice were perfused as described above and expression
of GFP was confirmed via fluorescence analysis.
Data Analysis and Statistics
All data are presented as mean 6 standard error of the mean
(S.E.M.). For comparisons of multiple groups, analysis of variance
(ANOVA) for random measures was performed followed by post
hoc Fisher’s test to determine statistically significant differences.
Figure 10. Requirement of presynaptic PKG-I for spinal facilitation of nociception induced by the NMDA-NO-cGMP pathway and
the natriuretic peptide-cGMP pathway. (A, B) Facilitation of latency to paw withdrawal (PWL) or tail-flick latency (TFL) following intrathecal
application of NMDA (100 fmol), the NO-donor or NOC-12 (17 nmol) in PKG-I
fl/fl mice (black squares), but not in SNS-PKG-I
2/2 mice (red circles). (C)
mRNA in situ hybridisation showing expression of the catalytic subunit of soluble guanylate cyclise (sGC) in populations of small-diameter neurons
(black arrows), large-diameter neurons (black arrowheads), and satellite cells (red arrows) in mouse DRG sections. Scale bar represents 50 mm. (D)
Facilitation of latency to paw withdrawal or tail-flick following intrathecal application of a natriuretic peptide cocktail (330 pmol each of ANP, BNP,
CNP) in PKG-I
fl/fl mice (black squares), but not in SNS-PKG-I
2/2 mice (red circles). All data points represent mean 6 S.E.M. * indicates significant
statistical difference (p,0.05, ANOVA, post hoc Fisher’s test) as compared to PKG-I
fl/fl mice, respectively. In all experiments, n=8–10 mice per
genotype or treatment group.
doi:10.1371/journal.pbio.1001283.g010
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2/2 mice by viral expression of GFP-tagged PKG-I specifically in
the L3-L4 dorsal root ganglia (DRG) of adult mice. (A) Photomicrographs showing expression of GFP-tagged PKG-I in the L4 DRG upon delivery
via adeno-associated virions (AAV). Scale bar represents 250 mm. (B) Basal mechanical sensitivity to graded mechanical stimuli (von Frey) is
unchanged upon overexpression of GFP-tagged PKG-I or GFP alone (control) in DRG neurons of PKG-I
fl/fl mice and SNS-PKG-I
2/2 mice. (C) PKG-I
fl/fl
mice expressing GFP-tagged PKG-I show a minor increase in magnitude of capsaicin-induced mechanical hypersensitivity than PKG-I
fl/fl mice
expressing GFP. { p,0.05 as compared to AAV-GFP-PKG-I
fl/fl mice. (D) SNS-PKG-I
2/2 mice overexpressing GFP in DRG show markedly reduced
mechanical hypersensitivity with capsaicin than PKG-I
fl/fl mice overexpressing GFP. Overexpression of GFP-tagged PKG-I fully restored mechanical
hypersensitivity in SNS-PKG-I
2/2 mice. { p,0.05 indicates significant differences in the AAV-GFP-SNS-PKG-I
2/2 mice as compared to the other two
groups. ANOVA followed by post hoc Fisher’s test.
doi:10.1371/journal.pbio.1001283.g011
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Student’s t test was employed. Unless otherwise specified, the p
values shown in the figures and text are derived from ANOVA
and post hoc Fisher’s test. p,0.05 was considered significant.
Supporting Information
Figure S1 Further evidence for specific deletion of PKG-I in
nociceptors, but not in spinal neurons. (A) Anti-Cre immunohis-
tochemistry on SNS-Cre mice demonstrating Cre expression in
small-diameter neurons of the DRG, but not in spinal cord. Scale
bars represent 50 mm for DRG and 100 mm for spinal cord. (B &
C) Western blot analysis reveals intact expression of PKG-I in the
spinal cord and brain and reduced expression in the DRG of SNS-
PKG-I
2/2 mice as compared to their PKG-I
fl/fl littermates.
Typical examples (B) and quantitative summary (C) from three
independent Western blot experiments; Tubulin expression serves
as a control. * p,0.001, ANOVA, post hoc Fisher’s test.
(PDF)
Figure S2 Further evidence for normal gross development of the
sensorimotor circuitry in SNS-PKG-I
2/2 mice. (A) Adult PKG-I
fl/fl
mice and SNS-PKG-I
2/2 mice show similar patterns of targeting
nociceptors in the spinal cord (upper panels) and the skin (lower
panels) as shown by binding to TRITC-labelled Isolectin-B4 (red)
and immunoreactivity for Substance P (Sub P) or CGRP (green).
Level of immunoreactivity for Sub P in spinal superficial laminae
was similar across genotypes (see results). (B) The density of synaptic
contacts between Sub P-containing nociceptor terminals and PSD-
95-expressing postsnyptic spines on spinal neurons in the spinal
superficial laminae is similar across genotypes. Quantitative values
on the right indicate mean percentage of association of substance P
and PSD-95. (C, D) Typical examples (C) and quantitative analysis
of heat pain-induced internalization of a Sub P receptor via NK1R
immunoreactivity in spinal dorsal horn neurons, which was
comparable across genotypes. (E) Normal spinal laminar develop-
ment in adult SNS-PKG-I
2/2 mice and their PKG-I
fl/fl littermates.
Cell bodies of spinal neurons were stained via anti-NeuN
immunohistochemistry. Scale bars represent 100 mm in panel A
and 2 mm in panel B. 15 mm in panel C and 100 mm in panel E.
(PDF)
Figure S3 Further validation of C-fiber-evoked synaptic long-
term potentiation (LTP) at spinal synapses in wild-type mice. (A)
Typical examples of retrogradely labelled spinal lamina I
projection neurons (lower panels) following DiI injections into
the PAG (upper panel). (B) LTP was preserved upon spinal
blockade of inhibitory neurotransmission with a combination of
bicuculline and strychnine; n=12 slices each. (C) Blockade of
PKG-I specifically in the postsynaptic neuron via application of
KT5823 in the patch pipette did not affect LTP; n=6 slices each.
(D) Quantitative summary of the magnitude of increase in c-
EPSCs in the above groups at 30 min after the conditioning
stimulus (LFS) over basal vales (normalized to 100). RKRARKE
represents a distinct PKG-I inhibitor, which was tested in parallel
experiments.
(PDF)
Figure S4 Magnitude of LTP at synapses between C-fibers and
spino-PAG neurons is plotted as a function of change in PPF or
PPD at the same synapse in SNS-PKG-I
2/2 mice and their PKG-
I
fl/fl littermates. It is noteworthy that in PKG-I
fl/fl mice, synapses
showing a large LTP show a decrease in PPF, indicating an
increase in the release probability. An increase in PPF is only seen
with a few synapses that do not show a robust LTP. These changes
do not come about in SNS-PKG-I
2/2 mice.
(PDF)
Figure S5 Nociceptive activity-driven phosphorylation of PKG-I
substrates in DRG and spinal cord in vivo. (A, B) A typical
example (A) and quantitative summary (B) of levels of VASP
phosphorylated on serine 239 in L4-L5 DRGs of SNS-PKG-I
2/2
mice and PKG-I
fl/fl littermates in the naı ¨ve state or following
formalin injection in the hindpaws. (C) Expression levels of total
VASP or MLC do not vary between the above experimental
groups. (D) Expression levels of total IP3R1 do not vary between
the above experimental groups. In all panels, quantitative
summaries are derived from three such independent experiments,
each involving eight mice/group. * p,0.05, ANOVA of random
measures followed by post hoc Fisher’s test. Data are represented
as mean 6 S.E.M.
(PDF)
Figure S6 Nociceptive withdrawal responses and development
of paw inflammation in SNS-PKG-I
2/2 mice and their PKG-I
fl/fl
littermates. (A) In comparison with PKG-I
fl/fl mice (n=8), SNS-
PKG-I
2/2 mice (n=8) show comparable paw withdrawal latency
(PWL; p=0.26) to radiant heat and paw withdrawal threshold
(PWT; p=0.24) to punctuate pressure. (B) Latency to fall from a
rotating rod was similar in SNS-PKG-I
2/2 mice (n=6) and PKG-
I
fl/fl mice (n=6). (C) The magnitude of paw edema was similar
between SNS-PKG-I
2/2 mice and their PKG-I
fl/fl littermates
following CFA-induced paw inflammation. Shown are comple-
mentary analyses of paw size in terms of paw volume (in cubic
mm; length6breadth6height) and volume of water displaced by
paws (in ml). All data points represent mean 6 S.E.M. n=8–10
mice per genotype or treatment group.
(PDF)
Text S1 Supplementary Methods and Materials.
(DOCX)
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